RxSight, Inc. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
RxSight, Inc. (RXST) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$27.98 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2026-08-05
- RxSight, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$12.10M.
- RxSight, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$15.88M.
- RxSight, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$9.15M.
- RxSight, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$9.82M.
- RxSight, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2025 was -$38.94M.
- RxSight, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was -$27.45M.
- RxSight, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$48.61M.
- RxSight, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$66.76M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$12.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$27.98M 10-Q · filed 2026-08-05 | -$37.13M derived: sum of 3 quarters · filed 2026-08-05 | -$46.95M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$15.88M 10-Q · filed 2026-05-06 | -$25.04M derived: sum of 2 quarters · filed 2026-05-06 | -$34.85M derived: sum of 3 quarters · filed 2026-05-06 | -$46.64M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$9.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$18.97M derived: sum of 2 quarters · filed 2026-02-25 | -$30.75M derived: sum of 3 quarters · filed 2026-08-05 | -$38.94M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$9.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$21.60M derived: sum of 2 quarters · filed 2026-08-05 | -$29.79M 10-Q · filed 2025-11-05 | -$35.73M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$11.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$19.98M 10-Q · filed 2026-08-05 | -$25.91M derived: sum of 3 quarters · filed 2026-08-05 | -$32.25M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$8.19M 10-Q · filed 2026-05-06 | -$14.13M derived: sum of 2 quarters · filed 2026-05-06 | -$20.47M derived: sum of 3 quarters · filed 2026-05-06 | -$26.55M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$5.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$12.28M derived: sum of 2 quarters · filed 2026-02-25 | -$18.36M derived: sum of 3 quarters · filed 2026-02-25 | -$27.45M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$6.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$12.42M derived: sum of 2 quarters · filed 2025-11-05 | -$21.52M 10-Q · filed 2025-11-05 | -$30.69M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$6.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$15.18M 10-Q · filed 2025-08-07 | -$24.36M derived: sum of 3 quarters · filed 2026-02-25 | -$36.77M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$9.10M 10-Q · filed 2025-05-07 | -$18.28M derived: sum of 2 quarters · filed 2026-02-25 | -$30.69M derived: sum of 3 quarters · filed 2026-02-25 | -$44.50M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$9.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$21.59M derived: sum of 2 quarters · filed 2026-02-25 | -$35.40M derived: sum of 3 quarters · filed 2026-02-25 | -$48.61M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$12.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$26.22M derived: sum of 2 quarters · filed 2024-11-07 | -$39.43M 10-Q · filed 2024-11-07 | -$55.04M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | -$13.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$27.02M 10-Q · filed 2024-08-05 | -$42.63M derived: sum of 3 quarters · filed 2025-02-25 | -$59.44M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | -$13.21M 10-Q · filed 2024-05-06 | -$28.82M derived: sum of 2 quarters · filed 2025-02-25 | -$45.64M derived: sum of 3 quarters · filed 2025-02-25 | -$62.37M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | -$15.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$32.43M derived: sum of 2 quarters · filed 2025-02-25 | -$49.16M derived: sum of 3 quarters · filed 2025-02-25 | -$66.76M 10-K · filed 2025-02-25 |
| 2022-09-30 | -$16.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$33.55M derived: sum of 2 quarters · filed 2023-11-09 | -$51.15M 10-Q · filed 2023-11-09 | -$66.88M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$16.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$34.33M 10-Q · filed 2023-08-07 | -$50.06M derived: sum of 3 quarters · filed 2023-08-07 | -$62.73M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | -$17.60M 10-Q · filed 2023-05-09 | -$33.33M derived: sum of 2 quarters · filed 2023-05-09 | -$46.00M derived: sum of 3 quarters · filed 2023-05-09 | -$59.48M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$15.73M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$28.41M derived: sum of 2 quarters · filed 2023-03-06 | -$41.88M derived: sum of 3 quarters · filed 2023-03-06 | -$48.69M 10-K · filed 2023-03-06 |
| 2021-09-30 | -$12.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$26.15M derived: sum of 2 quarters · filed 2022-11-07 | -$32.95M 10-Q · filed 2022-11-07 | -$6.66M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | -$13.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$20.28M 10-Q · filed 2022-08-08 | $6.01M derived: sum of 3 quarters · filed 2022-08-08 | $36.68M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | -$6.80M 10-Q · filed 2022-05-05 | $19.49M derived: sum of 2 quarters · filed 2022-05-05 | $50.15M derived: sum of 3 quarters · filed 2022-05-05 | |
| 2020-12-31 | $26.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $56.96M derived: sum of 2 quarters · filed 2022-03-08 | $27.57M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $30.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.28M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$29.38M 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |